HPV is also associated with most
oropharyngeal squamous cell carcinomas (OPSCCs), a disease in which distant metastatic disease can occur in up to 10 % of patients.
Identification of a human papillomavirus - associated oncogenic miRNA panel in human
oropharyngeal squamous cell carcinoma validated by bioinformatics analysis of the Cancer Genome Atlas.
NRG Oncology researchers recently developed and validated a nomogram that can predict 2 - year and 5 - year overall survival (OS) and progression - free survival (PFS) for patients with local - regionally advanced
oropharyngeal squamous cell carcinoma (OPSCC) treated primarily with radiation - based therapy.
Some 60 percent of
oropharyngeal squamous cell cancers now show traces of HPV.